ClassID:

21647

A61K2300/00 - page 8 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#2101
20180243269
2018-08-30

Forazolines, compositions thereof and uses thereof

#2102
20180243264
2018-08-30

Indoline derivatives for treatment and/or prevention of fibrosis diseases

#2103
20180243253
2018-08-30

FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS THEREOF AND MAQUI BERRY EXTRACT AND THERAPEUTIC USES THEREOF

#2104
20180243252
2018-08-30

Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma

#2105
20180243250
2018-08-30

Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor

#2106
20180243210
2018-08-30

METHOD FOR TREATING INTESTINAL FIBROSIS

#2107
20180237753
2018-08-23

Compositions and methods for enhancing virus replication

#2108
20180237746
2018-08-23

Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof

#2109
20180237467
2018-08-23

MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS

#2110
20180237453
2018-08-23

Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors

#2111
20180237403
2018-08-23

Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer

#2112
20180237381
2018-08-23

Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity

#2113
20180236101
2018-08-23

Thymidine kinase gene

#2114
20180236098
2018-08-23

ALPHA AND GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#2115
20180236084
2018-08-23

Method for enhancing specific immunotherapies in cancer treatment

#2116
20180236068
2018-08-23

Therapeutic agents for pancreatic cancer

#2117
20180236067
2018-08-23

Combination of the application of antibodies for immunostimulation together with glucocorticoids

#2118
20180236066
2018-08-23

METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS

#2119
20180236033
2018-08-23

PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME

#2120
20180236032
2018-08-23

COMBINATION COMPOSITION COMPRISING FGF-18 COMPOUND

#2121
20180236029
2018-08-23

Isoform Nell-1 peptide

#2122
20180236025
2018-08-23

METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE

#2123
20180236019
2018-08-23

Antimicrobial and antiviral composition

#2124
20180236018
2018-08-23

Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof

#2125
20180236002
2018-08-23

Compositions and methods for treating graft versus host disease

#2126
20180236000
2018-08-23

Prevention and treatment for microbial infections

#2127
20180235986
2018-08-23

COMBINATION THERAPY FOR CANCER TREATMENT

#2128
20180235980
2018-08-23

Pharmaceutical formulation

#2129
20180235970
2018-08-23

Compositions and methods for increasing energy metabolism

#2130
20180235964
2018-08-23

CXCR-2 inhibitors for treating crystal arthropathy disorders

#2131
20180235963
2018-08-23

Methods of administering elagolix

#2132
20180235961
2018-08-23

Compositions and methods for cancer expressing PDE3A or SLFN12

#2133
20180235947
2018-08-23

Liquid pharmaceutical composition

#2134
20180235940
2018-08-23

Treatment and management of augmentation in restless legs syndrome

#2135
20180235937
2018-08-23

Compounds and methods for treating an epileptic disorder

#2136
20180235935
2018-08-23

Treatment of Cancer with Enzalutamide and a CYP3A4 Inhibitor

#2137
20180235926
2018-08-23

Methods for controlling the spread of dirofilariosis

#2138
20180235924
2018-08-23

COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING BENZOYL PEROXIDE AND ADAPALENE

#2139
20180235922
2018-08-23

Pharmaceutical composition containing Bay 11-7082, parthenolide or a combination thereof for the treatment of obesity or cardiovascular diseases

#2140
20180235921
2018-08-23

Method of treating hyperglycemia

#2141
20180235917
2018-08-23

COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA

#2142
20180235911
2018-08-23

STABLE PHARMACEUTICAL COMPOSITION OF ALOGLIPTIN AND METFORMIN FIXED DOSE COMBINATION

#2143
20180235910
2018-08-23

Sigma receptor ligands and methods of modulating cellular protein homeostasis using same

#2144
20180235894
2018-08-23

Platelet membrane-coated drug delivery system

#2145
20180235886
2018-08-23

Carrier-binding agent compositions and methods of making and using the same

#2146
20180235870
2018-08-23

TRANSDERMAL FORMULATIONS FOR DELIVERY OF BERBERINE COMPOUNDS, AND THEIR USE IN THE TREATMENT OF BERBERINE-RESPONSIVE DISEASES AND CONDITIONS

#2147
20180231553
2018-08-16

Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent

#2148
20180230161
2018-08-16

Deuterated amlexanox

#2149
20180230134
2018-08-16

5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

#2150
20180230129
2018-08-16

Substituted pyridines as inhibitors of human immunodeficiency virus replication

#2151
20180230127
2018-08-16

Bicyclic-Fused Heteroaryl Or Aryl Compounds

#2152
20180230124
2018-08-16

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

#2153
20180228941
2018-08-16

PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION

#2154
20180228911
2018-08-16

Cross-linked star-shaped self-assembled polypeptides and its use as carriers in biomedical applications

#2155
20180228904
2018-08-16

FORMULATION FOR TOPICAL WOUND TREATMENT

#2156
20180228893
2018-08-16

Combinations and uses thereof

#2157
20180228881
2018-08-16

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

#2158
20180228842
2018-08-16

Biologically relevant orthogonal cytokine/receptor pairs

#2159
20180228822
2018-08-16

Interlaced Method for Treating Cancer or a Precancerous Condition

#2160
20180228814
2018-08-16

COMPOSITIONS & METHODS FOR LOWERING INTRAOCULAR PRESSURE

#2161
20180228813
2018-08-16

Oral Cephalotaxine Dosage Forms

#2162
20180228812
2018-08-16

THERAPEUTICAL USES OF ESLICARBAZEPINE

#2163
20180228804
2018-08-16

COMBINATION THERAPY OF HBV AND HDV INFECTION

#2164
20180228802
2018-08-16

5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer

#2165
20180228800
2018-08-16

COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS

#2166
20180228795
2018-08-16

COMBINATION THERAPY FOR CANCER

#2167
20180228775
2018-08-16

METHODS OF TREATING CANCER

#2168
20180228769
2018-08-16

Synergistic auristatin combinations

#2169
20180228760
2018-08-16

Antimicrobial compositions comprising mupirocin and neomycin

#2170
20180228759
2018-08-16

Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories

#2171
20180228747
2018-08-16

RECTAL TOPICAL LIPOGEL COMPRISING AN ANESTHETIC AGENT AND A NON-STEROIDAL ANTI-INFLAMMATORY AGENT FOR PAIN RELIEF

#2172
20180228745
2018-08-16

SUBSTANCE SELECTED AMONG MIDODRINE, A PHARMACEUTICAL SALT AND AN ACTIVE METABOLITE THEREOF, FOR USE IN THE TREATMENT OF OBSTRUCTIVE CARDIOPATHY

#2173
20180228744
2018-08-16

Adjuvant chemotherapy for anaplastic gliomas

#2174
20180228742
2018-08-16

Compositions for use in the treatment of diabetes

#2175
20180228740
2018-08-16

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

#2176
20180228739
2018-08-16

Dermal Delivery Device

#2177
20180228715
2018-08-16

DERMAL REJUVENATION COMPOSITIONS AND METHODS

#2178
20180224467
2018-08-09

METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS

#2179
20180222979
2018-08-09

Anti-CS1 antibodies and antibody drug conjugates

#2180
20180222956
2018-08-09

Method for treating myelofibrosis comprising administering a transforming growth factor beta type II receptor antagonist

#2181
20180222926
2018-08-09

Compositions and methods for inhibiting arginase activity

#2182
20180222890
2018-08-09

5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

#2183
20180222858
2018-08-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#2184
20180221498
2018-08-09

PH-sensitive linkers for delivering a therapeutic agent

#2185
20180221492
2018-08-09

Composition for use in treating and preventing inflammation related disorder

#2186
20180221479
2018-08-09

Agents for use in the treatment of glioma

#2187
20180221478
2018-08-09

TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)

#2188
20180221472
2018-08-09

Benzamide and active compound compositions and methods of use

#2189
20180221461
2018-08-09

Carbapenemases for use with antibiotics for the protection of the intestinal microbiome

#2190
20180221459
2018-08-09

ENZYME REPLACEMENT THERAPY FOR MUCOPOLYSACCHARIDOSIS IIID

#2191
20180221456
2018-08-09

BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA

#2192
20180221450
2018-08-09

Formulation Comprising A Stabilized Complex Of Corticotropin Releasing Hormone And Alpha-2 Macroglobulin

#2193
20180221444
2018-08-09

Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin

#2194
20180221439
2018-08-09

Antimicrobial fusion peptides

#2195
20180221438
2018-08-09

MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF

#2196
20180221436
2018-08-09

Treatments of oxidative stress conditions

#2197
20180221435
2018-08-09

ITCH TREATMENT USING A COMBINATION OF NEUROKININ-1, GASTRIN RELEASING PEPTIDE, AND GLUTAMATE RECEPTOR ANTAGONISTS

#2198
20180221433
2018-08-09

ANGIOTENSINS IN MUSCULAR DYSTROPHY

#2199
20180221412
2018-08-09

METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES

#2200
20180221406
2018-08-09

THERAPEUTIC COMBINATIONS OF ANTIVIRAL AND ANTI-INFLAMMATORY THERAPIES

#2201
20180221388
2018-08-09

Non-irritating testosterone emulsions

#2202
20180221382
2018-08-09

Inhibition of MK2 in the treatment of cancer

#2203
20180221381
2018-08-09

Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer

#2204
20180221376
2018-08-09

Methods for treating cancer using HSP90 inhibitors

#2205
20180221371
2018-08-09

TREATMENT FOR THE FETUS WITH CONGENITAL HEART DISEASE

#2206
20180221370
2018-08-09

Combination therapy

#2207
20180221369
2018-08-09

COMPOSITIONS AND METHODS FOR TREATING FIBROSING DISORDERS AND CANCER

#2208
20180221367
2018-08-09

Compounds and their use as BACE inhibitors

#2209
20180221366
2018-08-09

Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives

#2210
20180221358
2018-08-09

Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat

#2211
20180221355
2018-08-09

Use of gaboxadol in the treatment of tinnitus

#2212
20180221342
2018-08-09

Hepatitis C virus inhibitors

#2213
20180221339
2018-08-09

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS

#2214
20180221338
2018-08-09

Topical compositions comprising fipronil and permethrin and methods of use

#2215
20180221331
2018-08-09

PREVENTION OF ROSACEA INFLAMMATION

#2216
20180221320
2018-08-09

Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate

#2217
20180221315
2018-08-09

COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE

#2218
20180221311
2018-08-09

Materials and methods for controlling infections

#2219
20180221307
2018-08-09

TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE MANUFACTURED BY CO-EXTRUSION

#2220
20180221305
2018-08-09

ANTIMICROBIALS AND METHODS OF USE THEREOF FOR WOUND HEALING

#2221
20180221287
2018-08-09

Therapeutic composition comprising insulin prepared for delivery into an intestinal tract

#2222
20180221280
2018-08-09

Heat-stable dry powder pharmaceutical compositions and methods

#2223
20180215766
2018-08-02

Tetrahydroquinoline compositions as BET bromodomain inhibitors

#2224
20180215750
2018-08-02

Aminothiazole compounds and methods using same

#2225
20180215710
2018-08-02

METHODS FOR INHIBITING NATIVE AND PROMISCUOUS UPTAKE OF MONOAMINE NEUROTRANSMITTERS

#2226
20180214563
2018-08-02

IMMUNOSTIMULATORY NANOCARRIER

#2227
20180214547
2018-08-02

TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND IL-6

#2228
20180214544
2018-08-02

Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer

#2229
20180214526
2018-08-02

IMMUNOTHERAPY WITH BINDING AGENTS

#2230
20180214482
2018-08-02

METHOD OF ENABLING MUSCLE RELAXATION

#2231
20180214479
2018-08-02

Microporous zirconium silicate for the treatment of hyperkalemia

#2232
20180214464
2018-08-02

METHODS OF TREATING RETROVIRAL INFECTIONS AND RELATED DOSAGE REGIMES

#2233
20180214463
2018-08-02

USE OF PHYTIC ACID OR THE SALTS THEREOF, ALONE OR COMBINED WITH B6 VITAMERS, FOR PREVENTING THE FORMATION OF ADVANCED GLYCATION END-PRODUCT

#2234
20180214451
2018-08-02

Combination

#2235
20180214448
2018-08-02

Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

#2236
20180214442
2018-08-02

METHODS FOR ATTENUATING OR PREVENTING MU(μ)-OPIOID RECEPTOR MEDIATED TOLERANCE AND OPIOID-INDUCED HYPERALGESIA

#2237
20180214434
2018-08-02

SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE

#2238
20180214423
2018-08-02

Pharmaceutical composition comprising rapamycin or derivative thereof, and method for producing the same

#2239
20180214421
2018-08-02

COMPOSITIONS, METHODS AND KITS FOR REDUCING LIPID LEVELS

#2240
20180214409
2018-08-02

Compositions and methods of use of phorbol esters in the treatment of neoplasms

#2241
20180214405
2018-08-02

Methods of treating neurodevelopmental diseases and disorders

#2242
20180214399
2018-08-02

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

#2243
20180214398
2018-08-02

Topical compositions for pain relief, manufacture and use

#2244
20180214397
2018-08-02

Topical compositions for pain relief, manufacture and use

#2245
20180214393
2018-08-02

METHODS FOR TREATING CANCER

#2246
20180214373
2018-08-02

Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases

#2247
20180211566
2018-07-26

Skin punch biopsy and wound-debridgement training model

#2248
20180209997
2018-07-26

DIAGNOSTIC TOOLS FOR CHARCOT-MARIE-TOOTH DISEASE

#2249
20180209984
2018-07-26

Methods for cytotoxic chemotherapy-based predictive assays

#2250
20180208600
2018-07-26

BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF

#2251
20180208597
2018-07-26

Compounds for use in treating or preventing cancerous diseases

#2252
20180208573
2018-07-26

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#2253
20180207271
2018-07-26

IL-26 inhibitors

#2254
20180207268
2018-07-26

COMBINATION THERAPY FOR CANCER

#2255
20180207264
2018-07-26

PORCINE IMMUNE MODULATION MODEL

#2256
20180207226
2018-07-26

Compositions and methods for inhibition of bacterial infections in human endocervix

#2257
20180207225
2018-07-26

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA

#2258
20180207209
2018-07-26

BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS

#2259
20180207188
2018-07-26

TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN

#2260
20180207185
2018-07-26

METHODS OF TREATING MYELODYSPLASTIC SYNDROMES WITH A COMBINATION THERAPY USING LENALIDOMIDE AND AZACITIDINE

#2261
20180207177
2018-07-26

TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED), ANDROST-5-ENE-3b,7b,17b-TRIOL (b-AET) AND ESTRADIOL (E2)

#2262
20180207173
2018-07-26

ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS

#2263
20180207166
2018-07-26

Compounds and compositions for ossification and methods related thereto

#2264
20180207165
2018-07-26

METHODS AND COMPOSITIONS FOR STIMULATING BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT

#2265
20180207151
2018-07-26

Bupropion as a modulator of drug activity

#2266
20180207148
2018-07-26

THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER

#2267
20180207114
2018-07-26

ESTROGEN RELATED RECEPTOR GAMMA (ERRgamma) ENHANCES AND MAINTAINS BROWN FAT THERMOGENIC CAPACITY

#2268
20180206518
2018-07-26

METHOD OF MAKING CANNABIS OIL HYDROPHILIC USING EMULSIFIERS AND RELATED CANNABINOID COMPOSITIONS

#2269
20180206505
2018-07-26

Botanical Antimicrobial Compositions

#2270
20180201628
2018-07-19

Boron-containing diacylhydrazine compounds

#2271
20180201566
2018-07-19

Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

#2272
20180200370
2018-07-19

Pharmaceutical Composition Comprising a GLP-1 Agonist, an Insulin and Methionine

#2273
20180200369
2018-07-19

Vitamin E tocotrienols inhibition of intracellularly obligate pathogen Chlamydia and methods of use

#2274
20180200330
2018-07-19

Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System

#2275
20180200308
2018-07-19

METHODS OF TREATING COLITIS

#2276
20180200292
2018-07-19

COMPOSITIONS AND METHODS FOR OBTAINING AN IMPROVED LUNG FUNCTION

#2277
20180200280
2018-07-19

4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication

#2278
20180200274
2018-07-19

INHIBITORY COMPOSITIONS

#2279
20180200269
2018-07-19

Cholecalciferol sulfate salts and their use for the treatment of vitamin D deficiency

#2280
20180200263
2018-07-19

TOPICAL TREATMENT REGIMENS CONTAINING A PROSTAGLANDIN F2a ANALOG AND A TOPICAL STEROID

#2281
20180200257
2018-07-19

METHODS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#2282
20180200256
2018-07-19

Methods

#2283
20180200254
2018-07-19

ANTIVIRAL THERAPY

#2284
20180200248
2018-07-19

TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS

#2285
20180200244
2018-07-19

Methods of improving cell-based therapy

#2286
20180200240
2018-07-19

Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditions

#2287
20180200234
2018-07-19

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS

#2288
20180200231
2018-07-19

IL-8 inihibitors for use in the treatment of some urological disorders

#2289
20180200213
2018-07-19

Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes

#2290
20180200210
2018-07-19

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

#2291
20180200206
2018-07-19

TRANSPAPILLARY METHODS AND COMPOSITIONS FOR TREATING BREAST DISORDERS

#2292
20180200190
2018-07-19

MULTIPLE PILL ABUSE-RESISTANT IMMEDIATE RELEASE SOLID DOSAGE FORM OF HYDROCODONE

#2293
20180200164
2018-07-19

Buffered microencapsulated compositions and methods

#2294
20180199573
2018-07-19

CHEWABLE COMPOSITION COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT

#2295
20180195066
2018-07-12

Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach

#2296
20180194836
2018-07-12

PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT

#2297
20180194823
2018-07-12

Peptides and compositions for treatment of joint damage

#2298
20180194817
2018-07-12

Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition

#2299
20180194793
2018-07-12

Substituted nucleosides, nucleotides and analogs thereof

#2300
20180194737
2018-07-12

Hydantoins that modulate BACE-mediated APP processing

#2301
20180194709
2018-07-12

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

#2302
20180193483
2018-07-12

Drug formulation based on particulates comprising polysaccharide-vitamin conjugate

#2303
20180193461
2018-07-12

Pharmaceutical compositions to reduce complications of ocular steroid

#2304
20180193427
2018-07-12

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#2305
20180193418
2018-07-12

MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE

#2306
20180193414
2018-07-12

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

#2307
20180193404
2018-07-12

COMPOSITION FOR TREATMENT OF RSV

#2308
20180193402
2018-07-12

Method of increasing omega-3 content in poultry

#2309
20180193394
2018-07-12

Topical treatments incorporating . derived botanical drug product

#2310
20180193392
2018-07-12

infused sweeteners and elixirs

#2311
20180193391
2018-07-12

INDUCTION OF LAMINA PROPRIA REGULATORY T CELLS

#2312
20180193383
2018-07-12

Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer

#2313
20180193372
2018-07-12

NOVEL BIOMARKER FOR DIAGNOSING RESISTANCE TO ANTICANCER AGENT FOR BILLARY TRACT CANCER AND USE THEREOF

#2314
20180193367
2018-07-12

Method for prolonging the over survival of a cancer patient

#2315
20180193366
2018-07-12

Inhibition of HIV infection through chemoprophylaxis

#2316
20180193363
2018-07-12

Methods and compositions for protection of cells and tissues from computed tomography radiation

#2317
20180193347
2018-07-12

Tofacitinib oral sustained release dosage forms

#2318
20180193345
2018-07-12

INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS

#2319
20180193331
2018-07-12

Systems and methods for treating an opioid-induced adverse pharmacodynamic response

#2320
20180193317
2018-07-12

Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats

#2321
20180193316
2018-07-12

Drug compositions

#2322
20180193309
2018-07-12

Use of indole compounds for fat reduction and skin and soft tissue tightening

#2323
20180193302
2018-07-12

Ultra low dose doxepin and methods of using the same to treat sleep disorders

#2324
20180193295
2018-07-12

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

#2325
20180193273
2018-07-12

PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND DEXTROMETHORPHAN

#2326
20180193266
2018-07-12

EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

#2327
20180193263
2018-07-12

Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use

#2328
20180193254
2018-07-12

Medicament for the treatment of viral skin and tumour diseases

#2329
20180187158
2018-07-05

MULTIFUNCTIONAL IMMATURE DENTAL PULP STEM CELLS AND THERAPEUTIC APPLICATIONS

#2330
20180186890
2018-07-05

Anti-CD276 antibodies (B7H3)

#2331
20180186849
2018-07-05

Chimeric fibroblast growth factor 21 proteins and methods of use

#2332
20180186806
2018-07-05

ANTIVIRAL COMPOUNDS

#2333
20180186801
2018-07-05

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

#2334
20180186780
2018-07-05

Methods to treat lymphoplasmacytic lymphoma

#2335
20180186771
2018-07-05

Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them

#2336
20180186762
2018-07-05

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#2337
20180185519
2018-07-05

ASSESSMENT OF CORONARY HEART DISEASE WITH CARBON DIOXIDE

#2338
20180185514
2018-07-05

ST-246 liquid formulations and methods

#2339
20180185491
2018-07-05

Cochleates made with soy phosphatidylserine

#2340
20180185487
2018-07-05

Method to achieve extended expression of DNA infused into liver

#2341
20180185483
2018-07-05

COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER

#2342
20180185478
2018-07-05

Treatment for myopathy

#2343
20180185447
2018-07-05

Composition containing palmultang extract for promoting proliferation of stem cells derived from bone marrow

#2344
20180185409
2018-07-05

Use of potassium hydroxide in the treatment of actinic keratosis

#2345
20180185404
2018-07-05

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTION

#2346
20180185393
2018-07-05

Pharmaceutical composition containing Celecoxib

#2347
20180185385
2018-07-05

Preservative free bimatoprost and timolol solutions

#2348
20180185384
2018-07-05

DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA

#2349
20180185380
2018-07-05

Meloxicam for the treatment of respiratory diseases in pigs

#2350
20180185374
2018-07-05

INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS

#2351
20180185373
2018-07-05

METHODS AND COMPOSITIONS FOR TREATING THYROID-RELATED MEDICAL CONDITIONS WITH REDUCED FOLATES

#2352
20180185371
2018-07-05

Systems and methods for treating cancer

#2353
20180185365
2018-07-05

Pharmaceutical Combinations

#2354
20180185361
2018-07-05

Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy

#2355
20180185357
2018-07-05

Use of levocetirizine and montelukast in the treatment of traumatic injury

#2356
20180185354
2018-07-05

Immediate release abuse-deterrent granulated dosage forms

#2357
20180185353
2018-07-05

ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM

#2358
20180185351
2018-07-05

Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2

#2359
20180185350
2018-07-05

Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions

#2360
20180185347
2018-07-05

TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP

#2361
20180185345
2018-07-05

METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS

#2362
20180185338
2018-07-05

Treatment of BRCA1-defective cancer or resistant cancers

#2363
20180185337
2018-07-05

Therapeutic agent for dyslipidemia

#2364
20180185336
2018-07-05

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

#2365
20180185325
2018-07-05

12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME

#2366
20180185324
2018-07-05

NOVEL CANNABINOID COMBINATION THERAPIES FOR MULTIPLE MYELOMA (MM)

#2367
20180185321
2018-07-05

Talc-bound compositions and uses thereof

#2368
20180185319
2018-07-05

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

#2369
20180185318
2018-07-05

Combination methods and compositions including sleep therapeutics for treating mood

#2370
20180185314
2018-07-05

Compounds for the treatment of obesity and methods of use thereof

#2371
20180185311
2018-07-05

Modified release orally administered amino acid formulations

#2372
20180185304
2018-07-05

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#2373
20180185300
2018-07-05

Cannabidiol for the prevention and treatment of graft-versus-host disease

#2374
20180185291
2018-07-05

Pharmaceutical compositions

#2375
20180185284
2018-07-05

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

#2376
20180177883
2018-06-28

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof

#2377
20180177834
2018-06-28

Antiviral methods and compositions comprising probiotic bacterial molecules

#2378
20180177832
2018-06-28

Therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD

#2379
20180177831
2018-06-28

Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them

#2380
20180177824
2018-06-28

Compositions and methods for treating biofilms

#2381
20180177823
2018-06-28

Compositions and methods for aerodigestive treatment

#2382
20180177822
2018-06-28

Acetic acid and hypochlorous acid compositions for treatment of skin trauma

#2383
20180177813
2018-06-28

TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN

#2384
20180177809
2018-06-28

Composition comprising HMSs/HMOs and use thereof

#2385
20180177803
2018-06-28

Topical compositions and methods for treating psoriasis

#2386
20180177797
2018-06-28

Pharmaceutical compositions and methods for anesthesiological applications

#2387
20180177796
2018-06-28

Pharmaceutical compositions and methods for anesthesiological applications

#2388
20180177794
2018-06-28

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

#2389
20180177786
2018-06-28

MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER

#2390
20180177784
2018-06-28

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#2391
20180177773
2018-06-28

Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors

#2392
20180177748
2018-06-28

COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES

#2393
20180172668
2018-06-21

ENGINEERED MODEL OF FIBROTIC DISEASES

#2394
20180170916
2018-06-21

Inhibitors of CXCR2

#2395
20180170846
2018-06-21

Resorcinol derivatives

#2396
20180169256
2018-06-21

Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups

#2397
20180169231
2018-06-21

Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane

#2398
20180169229
2018-06-21

Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer

#2399
20180169204
2018-06-21

Combination vaccines with lower doses of antigen and/or adjuvant

#2400
20180169202
2018-06-21

Combination of vaccination and inhibition of the PD-1 pathway